Immuno-genetic biomarkers of response in a prospective study of immune checkpoint therapy in primary CNS lymphoma (2021–2025)

Grant type:
NHMRC MRFF Investigator Grant
Researchers:
Funded by:
Commonwealth Department of Health and Aged Care